LEPTOMENINGEAL DISEASE
Clinical trials for LEPTOMENINGEAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new LEPTOMENINGEAL DISEASE trials appear
Sign up with your email to follow new studies for LEPTOMENINGEAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Spinal vaccine trial targets breast cancer in the brain
⭐️ VACCINE ⭐️ OngoingThis early-phase study tests a new dendritic cell vaccine given directly into the spinal fluid for people with triple-negative or HER2-positive breast cancer that has spread to the lining of the brain (leptomeningeal disease). The main goal is to find the highest safe dose. About…
Matched conditions: LEPTOMENINGEAL DISEASE
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 09:08 UTC
-
New drug shows promise against brain tumors in advanced cancer
Disease control OngoingThis study tests a drug called QBS72S in 21 adults with advanced breast or lung cancer that has spread to the brain. The goal is to see if the drug can shrink brain tumors and help people live longer without the cancer getting worse. Participants must be 18 or older and in fairly…
Matched conditions: LEPTOMENINGEAL DISEASE
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated May 17, 2026 09:22 UTC